The evaluation of the serum homocysteine concentration in workers occupationally exposed to lead;Ocena steżenia homocysteiny w surowicy osób zawodowo narażonych na działanie ołowiu

Advances in Clinical and Experimental Medicine

Volumn 14, Issue 3, 2005, Pages 537-543

  Poreba, Rafał ^a   Skoczyńska, Anna ^a   Derkacz, Arkadiusz ^b   Szymańska Chabowska, Anna ^a   Andrzejak, Ryszard ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Wroclaw Medical University Katedra i Klinika Kardiologii   (Poland)

Author keywords

Atherosclerosis; Endothelium; Homocysteine; Lead

Indexed keywords

CHOLESTEROL; COPPER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LEAD; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LEAD POISONING; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PROTEIN BLOOD LEVEL; SMELTER; VASCULAR ENDOTHELIUM;

EID: 21644466344     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J, Rubba P, Bellet H, Wautrecht JC, de Valk HW, Sales Luis AC, Parrot-Rouland FM, Tan KS, Higgins I, Garcon D, Andria G: Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997, 277, 1775-1781.
2. Cybulska B, Adamus J, Bejnarowicz J, Janion M, Kornacewicz-Jach Z, Kuch J, Pajak A, Ruzyłło W, Rywik S, Szostak WB: Profilaktyka choroby niedokrwiennej serca. Rekomendacje Komisji Profilaktyki Polskiego Towarzystwa Kardiologicznego. Kardiol Pol 2000, 53, 1-48.
3. Mills BJ, Weiss MM, Lang CA, Liu MC, Ziegler C: Blood glutathion and cystein changes in cardiovascular disease. J Lab Clin Med 2000, 135, 396-401.
4. Kang SS, Wong PWK, Malinow MR: Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992, 12, 279-298.
5. Lutteri L, Chapelle JP, Gielen J: Homocysteine and cardiovascular risk. Rev Med Liege 1999, 54, 541-547.
6. Berg K: Molecular biology in the diagnosis of cardiovascular diseases. Tidsskar Nor Laegeforen 1998, 118, 2370-2374.
7. Eberhardt RT, Forgione MA, Cap A, Leopold JA, Rudd MA, Trolliet M, Heydrick S, Stark R, Klings ES, Moldovan NI, Yaghoubi M, Goldschmidt-Clermont PJ, Farber HW, Cohen R, Loscalzo J: Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest 2000, 106, 483-491.
8. Chen N, Liu Y, Greiner CD, Holtzman JL: Physiologic concentrations of homocysteine inhibit the human plasma GSH preoxidase that reduces organic hydroperoxides. J Lab Clin Med 2000, 136, 58-65.
9. Midorikawa S, Sanada H, Hashimoto S, Watanabe T: Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells. Biochem Biophys Res Commun 2000, 272, 182-185.
10. Andersson A, Hutlberg B, Lindgren A: Redox status of plasma homocysteine and other plasma thiols in stroke patients. Atherosclerosis 2000, 151, 535-539.
11. Choy PC, Mymin D, Zhu Q, Dakshinamurti K: Atherosclerosis risk factors: the possible role of homocysteine. Mol Cell Biochem 2000, 207, 143-148.
12. Woo DK, Dudrick SJ, Sumpio BE: Homocysteine stimulates MAP kinase in bovine aortic smooth muscle cells. Surgery 2000, 128, 59-66.
13. Skoczyńska A, Smolik R, Jeleń M: Lipid abnormalities in rats given small doses of lead. Arch Toxicol 1993, 67, 200-204.
14. Gatagonova TM: Characteristics of the serum lipids in workers of lead industry. Med Tr Prom Ekol 1994, 12, 17-21.
15. Shukla A, Shukla GS, Srimal RC: Cadmium-induced alterations in blood-brain barrier permeability and its possible correlation with decreased microvessel antioxidant potential in rat. Hum Exp Toxicol 1996, 15, 400-405.
16. Satoh K: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978, 90, 37-43.
17. Clarke R, Daly J, Robinson K: Hyperhomocysteinemia an independent risk factor for vascular disease. N Eng J Med 1991, 324, 1149-1155.
18. Boushey CJ, Berestford SA, Omenn GS: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274, 1049-1057.
19. Revis NW, Zinsmeister AR, Bull R: Atherosclerosis and hypertension induction by lead and cadmium ions: An effect prevented by calcium ion. Proc Natl Acad Sci 1981, 78, 6494-6498.
20. Skoczyńska A, Poreba R, Derkacz A: Endothelial dysfunction in workers exposed to lead. In: Atherosclerosis: risk factors, diagnosis, and treatment. Eds.: Kostner GM, Kostner KM. Monduzzi Editore, Bologna 2002, 77-81.